TCRX (tscan.com) Kacepetan wutah bathi saben saham ing taun lumaku
TScan Therapeutics (TCRX) demonstrates high macro resilience, as the success of cell therapy depends on medicine rather than GDP. On the GURU.Markets platform, the year-over-year EPS growth trend clearly illustrates a recovery in margins, where 20.30 determines the current status of the parameter. Growth potential is driven by massive demand for solid tumor treatments and the implementation of sustainable, zero-waste laboratory technologies.
Rincian metrik keuangan lan pasar tscan.com (TCRX)
- rega saham lan target rega konsensus:
- indikator valuasi pasar bisnis:
- data ekuitas miturut neraca:
- informasi babagan utang lan solvabilitas:
Rasio Total Utang marang Ekuitas TScan Therapeutics|TCRX - Utang jangka dawa marang modal|Utang jangka cendhak marang modal TScan Therapeutics, Inc.|TCRX - Utang perusahaan|Rasio utang marang nilai buku TCRX|TCRX - Kewajiban jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan TScan Therapeutics|Rasio likuiditas perantara tscan.com
- indikator bathi lan kelipatan valuasi:
TCRX - Bathi resik|Penghasilan resik sing dikarepake TScan Therapeutics|TCRX - Pangali P/E|Rasio prakiraan rega marang bathi TScan Therapeutics, Inc.|TCRX - Rasio rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan TCRX|TCRX - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) TScan Therapeutics|TCRX - Bathi saben saham sajrone rolas wulan pungkasan|Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan tscan.com|TCRX - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep TScan Therapeutics
Analisis dhasar perusahaan:TScan
TScan Therapeutics' unique T-cell therapy platform lays the foundation for long-term capitalization through personalized oncology. This indicator measures the annual dynamics of net earnings per share, allowing for an assessment of business scaling efficiency. The metric filters out short-term market noise to reveal the actual profitability trend. It is critical for investors to correlate this data with asset liquidity. By analyzing the year-over-year volatility of earnings per share, one can determine the sustainability of financial growth.
Pesaing wigati
BeiGene Ltd. - Tambahing bathi saben saham ing taun lumaku|HALO (Halozyme Inc.) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Revolution Medicines Corp RVMD|Wutah bathi resik saben saham ing taun iki AAPG (Ascentage Pharma Group)|Wutah bathi resik saben siji saham kanggo taun lumaku CGON|Wutah bathi saben saham ing taun lumaku UroGen Pharma URGN|Prakiraan wutah bathi resik saben saham ing taun iki Bicara Therapeutics Inc (BCAX)|Personalis Corp - Wutah bathi ing taun lumaku|Erasca Oncology (ERAS) - Wutah bathi resik saben saham ing taun iki|DCTH: Wutah bathi ing taun lumaku|ymabs.com (YMAB) - Wutah bathi ing taun lumaku|Wutah bathi saben saham ing taun lumaku Aura Biosciences|Wutah bathi saben saham ing taun iki CADL (Candel)|Wutah bathi resik saben saham ing taun iki ARAY (Accuray Inc.)|SLS (sellaslifesciences.com) - Tambahing bathi saben saham ing taun lumaku|Actuate Therapeutics, Inc. - Wutah bathi resik saben saham ing taun iki|Wutah bathi resik saben siji saham kanggo taun lumaku CTOR (citiusonc.com)|TuHURA - Wutah bathi ing taun lumaku|Tambahing bathi saben saham ing taun lumaku TARA (Protara Therapeutics Inc)|FATE: Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Aadi Bioscience (WHWK)|Wutah bathi saben saham ing taun lumaku Champions Oncology Inc|XBIT: Tambahing bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku CVM|Wutah bathi ing taun lumaku OS Therapies Inc. (OSTX)|Wutah bathi saben saham ing taun lumaku Radiopharm Theranostics RADX|ARTV (Artiva Biotherapeutics Inc.) - Dinamika bathi saben saham ing taun lumaku|Adlai Nortye Limited - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku verupharma.com|TPST (Tempest Therapeutics, Inc.) - Wutah bathi resik saben saham ing taun iki|Xilio Therapeutics (XLO) - Wutah bathi ing taun lumaku|Wutah bathi resik saben saham ing taun iki RENB|MURA (Mural Bio) - Wutah bathi resik saben siji saham kanggo taun lumaku|Wutah bathi ing taun lumaku KAPA|Prakiraan wutah bathi resik saben saham ing taun iki onkuretherapeutics.com|Wutah bathi ing taun lumaku GDTC (CytoMed Therapeutics Limited)|CRIS - Wutah bathi resik saben saham ing taun iki|APLM - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun iki Tharimmune Corporation THAR|ADVB (advanbiomed.com) - Wutah bathi resik saben saham ing taun iki|GNPX: Wutah bathi resik saben siji saham kanggo taun lumaku|CLDI (Calidi Biotherapeutics Inc.) - Wutah bathi ing taun lumaku|Wutah bathi resik saben saham ing taun iki sunshinebiopharma.com (SBFM)|Wutah bathi saben saham ing taun lumaku Xenetic Biosciences (XBIO)|SLRX (Salarius Pharma) - Tambahing bathi saben saham ing taun lumaku|Purple Biotech - Wutah bathi resik saben saham ing taun iki|AONC: Wutah bathi saben saham ing taun iki|BeiGene - Wutah bathi ing taun lumaku|Checkpoint Therapeutics Inc. (CKPT) - Wutah bathi resik saben saham ing taun iki|ELEV: Wutah bathi ing taun lumaku|iCAD (ICAD) - Wutah bathi ing taun lumaku|Wutah bathi saben saham ing taun lumaku Ikena Oncology Inc.|Wutah bathi saben saham ing taun iki NTBL (notablelabs.com)|Wutah bathi ing taun lumaku VIRX|Wutah bathi resik saben saham ing taun iki MorphoSys Inc MOR|Wutah bathi ing taun lumaku NAYA (NAYA Bio)|Ascentage (AAPGV) - Kacepetan wutah bathi saben saham ing taun lumaku
